Ductal Closure With Paracetamol: A Surprising New Approach to Patent Ductus Arteriosus Treatment

  • Hammerman C
  • Bin-Nun A
  • Markovitch E
 et al. 
  • 74

    Readers

    Mendeley users who have this article in their library.
  • 92

    Citations

    Citations of this article.

Abstract

Standard pharmacologic closure of the patent ductus arteriosus currently involves the administration of 1 of 2 cyclooxygenase inhibitors: either indomethacin or ibuprofen. However, both of these drugs can be associated with potentially significant adverse effects. We present here the cases of 5 preterm infants (gestational age: 26-32 weeks; postnatal age: 3-35 days) with large, hemodynamically significant patent ductus arteriosus who had either failed or had contraindications to ibuprofen therapy. Each of these infants was treated with off-label oral paracetamol (15 mg/kg per dose every 6 hours). Ductal closure was achieved within 48 hours in all the treated infants. No toxicity was observed.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • C. Hammerman

  • A. Bin-Nun

  • E. Markovitch

  • M. S. Schimmel

  • M. Kaplan

  • D. Fink

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free